The independent financial analyst theScreener just requalified the general evaluation of VITAMIN SHOPPE INCO. (US), active in the Specialty Retailers industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Negative. As of the analysis date December 10, 2019, the closing ...
A director at Vitamin Shoppe Inc bought 5,500 shares at 12.640USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Key Points: • The Staples Sector is leadership and many names are staging price and RS reversals. • REIT's are breaking above bases and are showing RS leadership. • Paper & Forest products are strengthening and many are reversing price and RS downtrend or breaking above bases. • Large-Cap Pharma stocks are showing leadership. Many have broken topside of multi-year consolidations or have reversed multi-year price and RS downtrends.
NEW ORLEANS--(BUSINESS WIRE)-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until October 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Vitamin Shoppe, Inc. (NYSE: VSI). Investor losses must relate to purchases of the Company’s shares between the expanded period of March 1, 2017 and August 8, 2017. This action is pending in the United States District Court for the District of New Jersey. Get Help Vitamin Shoppe investors ...
NEW YORK--(BUSINESS WIRE)-- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that October 27th is the deadline to move for lead plaintiff status in the class action against Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (NYSE:VSI). If you purchased Vitamin Shoppe common stock between March 1, 2017 and August 8, 2017, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information. Vitamin Shoppe is a s...
NEW ORLEANS--(BUSINESS WIRE)-- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until October 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Vitamin Shoppe, Inc. (NYSE: VSI). Investor losses must relate to purchases of the Company’s shares between the expanded period of March 1, 2017 and August 8, 2017. This action is pending in the United States District Court fo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.